Abstracts Archive - Page 173 of 1683 - ATC Abstracts

2022 American Transplant Congress
Steatosis Following Liver Transplantation for Nonalcoholic Steatohepatitis is Associated with a Higher Rate of Cardiovascular Complications
W. Alhamoudi¹, S. Alqahtani², K. Bzeizi², A. Albenmousa², Y. Saleh², D. Broering², S. Alghamdi²
¹Medicine, King Saud University, Riyadh, Saudi Arabia, ²Liver Transplantation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
*Purpose: Cirrhosis secondary to Nonalcoholic Steatohepatitis (NASH) is projected to become the leading indication for liver transplantation (LT) worldwide. Objectives: to evaluate the prevalence of…
2022 American Transplant Congress
Resource Utilization in Liver Transplant Patients Based on Psychological Evaluation of High Risk vs. Non-High Risk
K. Barber¹, D. Chism², R. Sauls³, R. Shargo³, M. Gosselin⁴, S. Mohammed³, K. Robichaux³, A. Kumar⁵, J. Buggs¹
¹Transplant Surgery, Tampa General Hospital, Tampa, FL, ²Lake Erie College of Osteopathic Medicine, Bradenton, FL, ³University of South Florida, Tampa, FL, ⁴University of Tampa, Tampa, FL, ⁵Morsani College of Medicine, University of South Florida, Tampa, FL
*Purpose: Psychological evaluation in liver transplant candidates helps to determine suitability. The psychological risk assessment results in the characterization of either low, medium, or high…
2022 American Transplant Congress
Intraabdominal Hypertension in the Death by Neurologic Criteria Organ Donor
C. Schardein¹, M. Moncure², S. Craft¹, S. Sanders³
¹General Surgery, University of Missouri at Kansas City, Kansas City, MO, ²Trauma and Critical Care Surgery, University of Missouri at Kansas City, Kansas City, MO, ³MTN, Kansas City, MO
*Purpose: This study attempts to identify the incidence of abdominal compartment syndrome (ACS) within the death by neurological criteria organ donor population, provide timely intervention,…
2022 American Transplant Congress
Risk Factors for Micafungin Non-Susceptible Invasive Candidiasis in Solid Organ Transplant Recipients
U. Dhal, J. Morillas-Rodriguez, K. D. Brizendine
Cleveland Clinic, Cleveland, OH
*Purpose: Determine risk factors associated with micafungin non-susceptible invasive candidiasis (IC) in solid organ transplant (SOT) recipients*Methods: We conducted a retrospective study of SOT patients…
2022 American Transplant Congress
Can dd-cf DNA Eliminate Unnecessary Biopsies? The Answer is Yes!
K. Andreoni, Y. Chalicheemala, M. Debroy, M. Maklad, K. Zhao, M. Aeder, A. Jittirat, D. Ecabert, A. Bixby, C. Burrelli, K. Chavin
University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: Historically our center has been one that routinely performs biopsies. We perform them pre-perfusion, for slowly recovering allografts between day 10-14, and routinely at…
2022 American Transplant Congress
Center Volume and Transplant Outcomes in Adult Kidney Transplant Recipients; A Competing Risk Analysis
A. Azhar¹, E. Defor¹, L. Kamal¹, D. Bandyopadhyay¹, B. Tanriover², G. Gupta¹
¹Virginia Commonwealth University, Richmond, VA, ²University of Arizona, Tuscon, AZ
*Purpose: The precise effect of center volume is a much-debated topic in the field of transplantation. Several studies have shown better post-transplant outcomes in higher…
2022 American Transplant Congress
De Novo Focal Segmental Glomerulosclerosis in the Kidney Allograft: Association with Alloimmunity Leading to Poor Outcome
J. Leon¹, J. Duong Van Huyen², A. Abderrahmane¹, D. Anglicheau¹, C. Legendre¹, M. Rabant²
¹KIDNEY TRANSPLANTATION, Necker Hospital, Paris, France, ²KIDNEY PATHOLOGY, Necker Hospital, Paris, France
*Purpose: Focal Segmental Glomerulosclerosis (FSGS) can be found de novo (Dn) or as a recurrence in kidney allograft. While FSGS recurrence has been extensively described…
2022 American Transplant Congress
Outcomes in Hepatitis C (HCV) Viremic Grafts to HCV Negative Recipients in Heart Transplantation: A Multicenter Study of Differing Treatment Strategies
K. Ryland¹, B. Aqel², D. Steidley², P. Patel¹, S. Pungpapong³
¹Mayo Clinic, Jacksonville, FL, ²Mayo Clinic, Phoenix, AZ, ³Mayo Clinic College of Medicine, Jacksonville, FL
*Purpose: Using HCV viremic grafts for heart transplantation (HT) improves donor supply and shortens wait times. However, treatment strategies are variable post-transplant. This study aims…
2022 American Transplant Congress
Internal Validation of a Pre-Transplant Biomarker Panel to Predict Post-Transplant Mortality: The Liver Immune Frailty Index
G. G. Panayotova¹, D. T. Nguyen², E. A. Graviss², L. J. Minze², S. Simonishvili¹, Y. Qin¹, T. Ayorinde¹, G. Prakash¹, F. Paterno¹, L. Brown¹, A. Amin¹, X. C. Li², R. M. Ghobrial², J. V. Guarrera¹, K. E. Lunsford¹
¹Rutgers New Jersey Medical School, Newark, NJ, ²Houston Methodist Hospital, Houston, TX
*Purpose: Infection and sepsis are the greatest contributors to early post-liver transplant (LT) mortality. These often result from ongoing immune dysfunction, or “Immune Frailty”. We…
2022 American Transplant Congress
Functional Recellularized Patient Derived Endothelium; A Human Vascular Graft Approach
H. Tejeda Mora¹, J. Willemse², Y. den Hartog¹, I. Schurink², M. M. Verstegen², J. de Jonge², R. C. Minnee², M. W. van den Hoogen², C. C. Baan¹, L. J. van der Laan², M. J. Hoogduijn¹
¹Transplant Institute - Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands, ²Transplant Institute - Department of Surgery, Erasmus Medical Center, Rotterdam, Netherlands
*Purpose: In transplantation, the endothelial lining is the first barrier between the donor organ and recipient immune system. Damaged endothelium exposes extracellular matrix (ECM) molecules…